Get early access! Join the Twelve Data AI Assistant waitlist now.
12.55000 CAD
0.2
1.57%
Last update Sep 9, 3:01 PM EDT
Market closed
Day range
12.53000
12.75
Previous close
12.75
Open
12.75
Access this stock data via API
Subscribe
Innocan Pharma Corporation
12.55
0.20
1.57%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 9.7M 10.8M 7.5M 11.9M
Cost of revenue 1.1M 942.9K 1.4M 1.2M
Gross profit 8.6M 9.9M 6.1M 10.8M
Operating expense
Research & development 243.7K 249.2K 447.2K 522.0K
Selling general and admin 7.8M 8.9M 6.9M 9.8M
Other operating expenses
Operating income 548.3K 677.1K -1.3M 487.4K
Non operating interest income
Income 0 0
Expense 5.5K 4.2K 4.2K 2.8K
Other income expense -693.7K -627.2K 1.3M 487.4K
Pretax income -150.9K 45.7K 4.2K 972.0K
Tax provision 285.2K 362.8K 70.6K 578.8K
Net income -436.2K -317.1K -66.5K 393.2K
Basic EPS 0.0 0.0 0.0
Diluted EPS 0.0 0.0 0.0
Basic average shares 404.6M 402.0M 390.0M
Diluted average shares 404.6M 402.0M 390.0M
EBITDA 560.8K 690.9K -1.3M 499.8K
Net income from continuing op. -436.2K -317.1K -66.5K 393.2K
Minority interests -380.8K -488.8K -91.4K -794.8K
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 13 hours 31 minutes

18:28
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/Toronto timezone (EDT, UTC-04:00).